all report title image

STERNAL CLOSURE SYSTEMS MARKET ANALYSIS

Sternal Closure Systems Market, by Product Type (Closure Devices and Bone Cement), by Material Type (Stainless Steel, PEEK, and Titanium), by Procedure (Median Sternotomy, Hemisternotomy, and Bilateral Thoracosternotomy), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Sep 2024
  • Code : CMI2370
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Sternal Closure Systems MarketSize and Trends

Sternal Closure Systems Market: Dynamics

Increasing prevalence of cardiovascular diseases is a major factor propelling demand for sternal closure systems. According to a report by the American Heart Association (AHA), 2015, around 84 million people in the U.S. suffered from some or the other form of cardiovascular disease (CVD) in 2017 and around 130 million adults constituting over 45% of the country’s population, are estimated to suffer from at least one CVD by 2035. Moreover, launch of innovative devices to produce tight closure and stable union at sternum for patients undergoing cardiothoracic surgery is also expected to boost the market growth. For instance, in 2015, the U.S. FDA approved the Grand Pre Monoblock Closure System developed by JACE Medical, LLC. The rigid closure system is biocompatible and uses ratchet technology to close the space tightly and promote healing.

Similarly, in 2013, RTI Surgical launched, Tritium Sternal Cable Plating (SCP) system designed for the closure of median sternotomies following open-heart surgeries. The system combines cerclage cables and cancellous screws, with a low profile plate.

Sternal Closure Systems Market: Dynamics

Increasing prevalence of cardiovascular diseases is a major factor propelling demand for sternal closure systems. According to a report by the American Heart Association (AHA), 2015, around 84 million people in the U.S. suffered from some or the other form of cardiovascular disease (CVD) in 2017 and around 130 million adults constituting over 45% of the country’s population, are estimated to suffer from at least one CVD by 2035. Moreover, launch of innovative devices to produce tight closure and stable union at sternum for patients undergoing cardiothoracic surgery is also expected to boost the market growth. For instance, in 2015, the U.S. FDA approved the Grand Pre Monoblock Closure System developed by JACE Medical, LLC. The rigid closure system is biocompatible and uses ratchet technology to close the space tightly and promote healing.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.